A comparison of fluticasone furoate nasal spray versus oral fexofenadine in the treatment of seasonal allergic rhinitis

Trial Profile

A comparison of fluticasone furoate nasal spray versus oral fexofenadine in the treatment of seasonal allergic rhinitis

Completed
Phase of Trial: Phase IV

Latest Information Update: 15 Dec 2016

At a glance

  • Drugs Fexofenadine (Primary) ; Fluticasone furoate (Primary)
  • Indications Seasonal allergic rhinitis
  • Focus Therapeutic Use
  • Sponsors GlaxoSmithKline
  • Most Recent Events

    • 01 Apr 2009 Results reported in Allergy and Asthma Proceedings.
    • 09 Apr 2008 Status changed from in progress to completed, as reported in ClinicalTrials.gov.
    • 17 Mar 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top